A comparative analysis of remdesivir and other repurposed antivirals against SARS‐CoV‐2

Alexander Simonis(University of Cologne), Jakob J Malin(University of Cologne), Jan Rybniker(University of Cologne), Sebastian J. Theobald(University of Cologne), Gerd Fätkenheuer(University of Cologne)
EMBO Molecular Medicine
October 5, 2020
10.15252/emmm.202013105
Cited by 86

Related Papers

Daptomycin versus Standard Therapy for Bacteremia and Endocarditis Caused by <i>Staphylococcus aureus</i>
|New England Journal of Medicine|2006|1.5k
Swarm Learning for decentralized and confidential clinical machine learning
|Nature|2021|833
Antiretroviral Drugs for Treatment and Prevention of HIV Infection in Adults
|JAMA|2018|557
Antiretroviral Drugs for Treatment and Prevention of HIV Infection in Adults
|JAMA|2020|466
Long‐lived macrophage reprogramming drives spike protein‐mediated inflammasome activation in COVID‐19
|EMBO Molecular Medicine|2021|154